It is increasingly clear that the speed of drug discovery is critical in enabling us to address the needs of modern healthcare which span from infectious diseases to oncology. To accelerate the drug discovery process, unique platforms are needed that can identify and validate lead molecules in a cost-effective manner. In this webinar, our senior scientist of Reagent Antibody Services talks about the key factors in drug discovery and how GenScript can help in accelerating the process from start to finish.
A comprehensive drug development platform to integrate antibody engineering and antibody production technologies with extensive experience in services such as antibody sequencing and antibody humanization.
Microsystem-based screening method that harnesses the latest optofluidics technology, and combines the isolation, screening and evaluation of B cells on a chip, with the integration of high throughput platforms for assay screening.
Custom kits that enable the reliable detection and quantitation of your unique antigen. Each kit undergoes extensive assay development and validation to ensure its sensitivity against your desired target.
